Home
Home

pimavanserin

Acadia Gets Expedited FDA Review Path for Lead Drug

Acadia Gets Expedited FDA Review Path for Lead Drug
Bloomberg

Is There Any Potential Left In ACADIA Pharmaceuticals?

Is There Any Potential Left In ACADIA Pharmaceuticals?
Seeking Alpha

Shares of Acadia Pharma jump on confidence a top drug candidate will be approved

Shares of Acadia Pharma jump on confidence a top drug candidate will be approved
Yahoo/AP

Acadia Hits Home Run In Phase III Trial And Brings Market Focus To Parkinson's

Acadia Hits Home Run In Phase III Trial And Brings Market Focus To Parkinson's
Seeking Alpha

Acadia Rockets Into The Stratosphere On Clinical Trial Data

Acadia Rockets Into The Stratosphere On Clinical Trial Data
Seeking Alpha

Acadia Pharmaceuticals And Galena Biopharma: What A Difference A Trial Design Can Make

Acadia Pharmaceuticals And Galena Biopharma: What A Difference A Trial Design Can Make
Seeking Alpha

Acadia climbs as company says pimavanserin reduced psychosis in Parkinson's disease patients

Acadia climbs as company says pimavanserin reduced psychosis in Parkinson's disease patients
Yahoo/AP

Acadia's Bubbling To Move Higher

Acadia's Bubbling To Move Higher
Seeking Alpha

Acadia: A Big Move Into Parkinson's Disease Psychosis Results

Acadia: A Big Move Into Parkinson's Disease Psychosis Results
Seeking Alpha

Acadia Pharmaceuticals Poised For 100% Gain By December

Acadia Pharmaceuticals Poised For 100% Gain By December
Seeking Alpha